Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological Myelopoiesis.
Cancer Res
; 76(21): 6253-6265, 2016 11 01.
Article
in En
| MEDLINE
| ID: mdl-27803104
Full text:
1
Database:
MEDLINE
Main subject:
Pyridones
/
Pyrimidinones
/
T-Lymphocytes
/
Proto-Oncogene Proteins p21(ras)
/
Myelopoiesis
/
Mutation
/
Neoplasms
/
Antineoplastic Agents
Limits:
Animals
/
Female
/
Humans
Language:
En
Year:
2016
Type:
Article